• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒亚端粒DNA低甲基化对于ALT细胞中的端粒姐妹染色单体交换并非必需。

Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells.

作者信息

Tilman G, Loriot A, Van Beneden A, Arnoult N, Londoño-Vallejo J A, De Smet C, Decottignies A

机构信息

Faculty of Medicine, Genetic and Epigenetic Alterations of The Genome Group, de Duve Institute, Catholic University of Louvain, Brussels, Belgium.

出版信息

Oncogene. 2009 Apr 9;28(14):1682-93. doi: 10.1038/onc.2009.23. Epub 2009 Mar 2.

DOI:10.1038/onc.2009.23
PMID:19252523
Abstract

Most human tumor cells acquire immortality by activating the expression of telomerase, a ribonucleoprotein that maintains stable telomere lengths at chromosome ends throughout cell divisions. Other tumors use an alternative mechanism of telomere lengthening (ALT), characterized by high frequencies of telomeric sister chromatid exchanges (T-SCEs). Mechanisms of ALT activation are still poorly understood, but recent studies suggest that DNA hypomethylation of chromosome ends might contribute to the process by facilitating T-SCEs. Here, we show that ALT/T-SCE(high) tumor cells display low DNA-methylation levels at the D4Z4 and DNF92 subtelomeric sequences. Surprisingly, however, the same sequences retained high methylation levels in ALT/T-SCE(high) SV40-immortalized fibroblasts. Moreover, T-SCE rates were efficiently reduced by ectopic expression of active telomerase in ALT tumor cells, even though subtelomeric sequences remained hypomethylated. We also show that hypomethylation of subtelomeric sequences in ALT tumor cells is correlated with genome-wide hypomethylation of Alu repeats and pericentromeric Sat2 DNA sequences. Overall, this study suggests that, although subtelomeric DNA hypomethylation is often coincident with the ALT process in human tumor cells, it is not required for T-SCE.

摘要

大多数人类肿瘤细胞通过激活端粒酶的表达而获得永生,端粒酶是一种核糖核蛋白,在整个细胞分裂过程中维持染色体末端端粒长度的稳定。其他肿瘤则采用端粒延长的替代机制(ALT),其特征是端粒姐妹染色单体交换(T-SCE)的频率很高。ALT激活的机制仍知之甚少,但最近的研究表明,染色体末端的DNA低甲基化可能通过促进T-SCE而有助于这一过程。在这里,我们表明ALT/T-SCE(高)肿瘤细胞在D4Z4和DNF92亚端粒序列处显示出低DNA甲基化水平。然而,令人惊讶的是,相同的序列在ALT/T-SCE(高)的SV40永生化成纤维细胞中保留了高甲基化水平。此外,即使亚端粒序列仍然低甲基化,ALT肿瘤细胞中活性端粒酶的异位表达也能有效降低T-SCE率。我们还表明,ALT肿瘤细胞中亚端粒序列的低甲基化与Alu重复序列和着丝粒周围Sat2 DNA序列的全基因组低甲基化相关。总体而言,这项研究表明,尽管亚端粒DNA低甲基化在人类肿瘤细胞中通常与ALT过程同时发生,但它不是T-SCE所必需的。

相似文献

1
Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells.端粒亚端粒DNA低甲基化对于ALT细胞中的端粒姐妹染色单体交换并非必需。
Oncogene. 2009 Apr 9;28(14):1682-93. doi: 10.1038/onc.2009.23. Epub 2009 Mar 2.
2
Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions.ICF综合征中染色体亚端粒区域的低甲基化与异常短的端粒及端粒区域转录增强相关。
Hum Mol Genet. 2008 Sep 15;17(18):2776-89. doi: 10.1093/hmg/ddn177. Epub 2008 Jun 16.
3
DNA methyltransferases control telomere length and telomere recombination in mammalian cells.DNA甲基转移酶控制哺乳动物细胞中的端粒长度和端粒重组。
Nat Cell Biol. 2006 Apr;8(4):416-24. doi: 10.1038/ncb1386. Epub 2006 Mar 26.
4
Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?端粒的替代延长(ALT)与染色质:它们之间有关联吗?
Biochimie. 2008 Jan;90(1):5-12. doi: 10.1016/j.biochi.2007.08.009. Epub 2007 Sep 2.
5
Telomere exchange and asymmetric segregation of chromosomes can account for the unlimited proliferative potential of ALT cell populations.端粒交换和染色体的不对称分离可以解释ALT细胞群体无限的增殖潜力。
DNA Repair (Amst). 2008 Feb 1;7(2):199-204. doi: 10.1016/j.dnarep.2007.09.012. Epub 2007 Nov 19.
6
Telomere length maintenance--an ALTernative mechanism.端粒长度维持——一种替代机制。
Cytogenet Genome Res. 2008;122(3-4):281-91. doi: 10.1159/000167814. Epub 2009 Jan 30.
7
Epigenetic regulation of telomeres in human cancer.人类癌症中端粒的表观遗传调控。
Oncogene. 2008 Nov 20;27(54):6817-33. doi: 10.1038/onc.2008.289. Epub 2008 Sep 1.
8
A novel telomere structure in a human alternative lengthening of telomeres cell line.一种人类端粒延长替代细胞系中的新型端粒结构。
Cancer Res. 2005 Apr 1;65(7):2730-7. doi: 10.1158/0008-5472.CAN-04-2888.
9
Pericentromeric instability and spontaneous emergence of human neoacrocentric and minute chromosomes in the alternative pathway of telomere lengthening.端粒延长替代途径中人类新着丝粒染色体和微小染色体的着丝粒周围不稳定性及自发出现
Cancer Res. 2008 Oct 1;68(19):8146-55. doi: 10.1158/0008-5472.CAN-08-0945.
10
The first molecular details of ALT in human tumor cells.人类肿瘤细胞中ALT的首个分子细节。
Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R191-6. doi: 10.1093/hmg/ddi266.

引用本文的文献

1
A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches.癌症与衰老中端粒损耗的综述:当前的分子见解及未来的治疗方法
Cancers (Basel). 2025 Jan 14;17(2):257. doi: 10.3390/cancers17020257.
2
The TERT Promoter is Polycomb-Repressed in Neuroblastoma Cells with Long Telomeres.端粒酶逆转录酶启动子在端粒较长的神经母细胞瘤细胞中受到多梳抑制。
Cancer Res Commun. 2024 Jun 20;4(6):1533-1547. doi: 10.1158/2767-9764.CRC-22-0287.
3
Cell Immortalization: In Vivo Molecular Bases and In Vitro Techniques for Obtention.
细胞永生化:体内分子基础与体外获取技术
BioTech (Basel). 2023 Jan 28;12(1):14. doi: 10.3390/biotech12010014.
4
Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.靶向端粒:端粒维持机制特异性癌症治疗的进展。
Nat Rev Cancer. 2022 Sep;22(9):515-532. doi: 10.1038/s41568-022-00490-1. Epub 2022 Jul 5.
5
Alternative Lengthening of Telomeres and Mediated Telomere Synthesis.端粒替代延长和介导的端粒合成
Cancers (Basel). 2022 Apr 27;14(9):2194. doi: 10.3390/cancers14092194.
6
Detection of alternative lengthening of telomeres mechanism on tumor sections.肿瘤切片中端粒替代延长机制的检测。
Mol Biomed. 2021 Oct 20;2(1):32. doi: 10.1186/s43556-021-00055-y.
7
Epigenetic Characteristics of Human Subtelomeres Vary in Cells Utilizing the Alternative Lengthening of Telomeres (ALT) Pathway.人类亚端粒的表观遗传特征在利用端粒替代延长(ALT)途径的细胞中存在差异。
Life (Basel). 2021 Mar 26;11(4):278. doi: 10.3390/life11040278.
8
NHP2 downregulation counteracts hTR-mediated activation of the DNA damage response at ALT telomeres.NHP2表达下调可抵消hTR介导的在端粒延长(ALT)型端粒处的DNA损伤反应激活。
EMBO J. 2021 Mar 15;40(6):e106336. doi: 10.15252/embj.2020106336. Epub 2021 Feb 17.
9
PAR-TERRA is the main contributor to telomeric repeat-containing RNA transcripts in normal and cancer mouse cells.PAR-TERRA 是正常和癌细胞中端粒重复 RNA 转录本的主要贡献者。
RNA. 2021 Jan;27(1):106-121. doi: 10.1261/rna.076281.120. Epub 2020 Oct 30.
10
Repression of TERRA Expression by Subtelomeric DNA Methylation Is Dependent on NRF1 Binding.端粒外 DNA 甲基化对 TERRA 表达的抑制依赖于 NRF1 结合。
Int J Mol Sci. 2019 Jun 7;20(11):2791. doi: 10.3390/ijms20112791.